Abstract
Abstract INTRODUCTION Though it remains a rare and devastating tumor, great strides have been taken to improve prognostication and treatment paradigms for patients with skull base chordoma. With respect to surgical techniques, lateral transcranial (TC) approaches have traditionally been used, however endoscopic endonasal approaches (EEA) have been advocated for midline lesions. However, due to the rarity of this tumor (0.2% of all intracranial neoplasms), investigations within the literature remain limited to small retrospective series. METHODS Accordingly, we performed a systematic review and meta-analysis in order to profile surgical outcomes for midline versus lateral approaches to resection of skull base chordoma. Meta-analysis of pooled mortality rates and sub-analyses of operative margin and surgical complications were used to compare midline versus lateral approaches via the Mantel-Haenszel method. We considered all p-values < 0.05 to be statistically significant. RESULTS Fifty studies published between 1993-2022 reporting data for 2252 patients remained eligible for analysis. Average age at diagnosis was 42.4 ± 12.5 years, while average age of treatment initiation was 43.0 ± 10.6 years. The relative risk for mortality (Figure 2) in patients undergoing surgical intervention was -0.93 [-1.03,-0.97], I^2=95%, (p < 0.001), indicating low surgery-related mortality rates. From the seven studies eligible for formal meta-analysis, we found that there was no statistically significant difference between midline and lateral approaches with respect to rates of GTR or recurrence. Nor was there a significant difference between rates of postoperative cranial nerve dysfunction, although the result trended toward favoring midline approaches. Finally, midline approaches exhibited a lower odds for peri- and post-operative complications, including CSF leak (OR 0.59 [0.35, 0.97], I^2 = 0%, p = 0.04). CONCLUSION Ultimately, there are no striking differences between midline versus lateral approaches to resection of skull base chordoma, particularly as they relate to operative margins, recurrence, or rates of cranial nerve palsy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
More From: Neuro-Oncology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.